TrialIndian journal of ophthalmology2023

Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre.

Kalpna Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.